A meta-analysis of 18 BCa studies demonstrated that preoperative low albumin was significantly associated with inferior overall survival (OS) (HR = 1.88), cancer-specific survival (CSS) (HR = 1.69), 30-day postoperative complications (HR = 1.55), and 90-day mortality (HR = 2.87) (24). The gene discussed is ALB; the disease is cancer.